Tiny iron oxide particles can imitate natural enzymes and, on top of that, they obey a magnet. It sounds like the recipe for a miracle catalyst, but the road from an impressive lab result to safe use is a long one. A European team stopped multiplying new particles and took a close look at their surface instead. The conclusion goes beyond materials science: the strongest reaction is not always the best one — and at the end you can check whether you, too, know how to find the golden mean.
Labs around the world regularly show how much potential lies in active nanocatalysts. The catch is that real-world success requires a balance between efficiency and biocompatibility. That is exactly what the NESTOR project set out to tackle. It was funded by the EU through the Marie Skłodowska-Curie Actions and coordinated by the University of Zaragoza in Spain.
The stars of the research are magnetic nanozymes based on iron oxide. They are a new class of artificial enzymes that mimic their natural counterparts, and they have a feature biology never gave them: they can be easily guided and recovered using external magnetic fields.
Activity alone is not enough, though. The main challenge is predicting and controlling the selectivity, robustness, reproducibility and biological safety of such materials in real-world environments, not just in a carefully prepared experiment. A single material can behave very differently depending on pH, clumping or the surrounding biological environment.
That is why the NESTOR team decided to look at the chemical, magnetic and biological traits of nanozymes not in isolation, but as a whole.
The key decision was what to focus on in the first place. Project coordinator Gerardo F. Goya explains it plainly: “Rather than simply synthesising different nanoparticle materials to optimise individual properties, we focused on learning how to engineer iron-oxide surfaces so that catalytic activity, magnetic response and biological safety could be controlled within a single material platform.”
The team moved the nanozyme field away from a purely empirical, trial-and-error approach — testing one variant after another and seeing what works — towards a robust mechanistic framework. The researchers wanted to understand how the surface features of a nanoparticle dictate the chemical pathways it uses to either generate or destroy reactive molecules. The processes under study included Fenton-like, peroxidase-like and catalase-like reactions. The team looked closely at the role of:
By comparing how changes in cation distribution, redox state and surface structure affect performance and biological response, the team could predict behaviours that were once entirely unexpected.
The most interesting conclusion came early on. “We recognised early that higher catalytic activity is not always better. Because oxidative stress is a double-edged mechanism, it can be harnessed for antimicrobial action, environmental remediation and cancer-related therapies, but it must be carefully controlled to prevent unintended cellular damage,” explains Goya.
Safety was therefore not an add-on at the very end, but one of the equal goals from the start. “To strike a realistic, safe balance between chemical performance and biocompatibility, we systematically evaluated cytotoxicity and genotoxicity in advanced in vitro models,” the coordinator adds.
The biological tests were paired with advanced characterisation techniques: high-resolution electron microscopy, spectroscopic analysis and magnetometry. A multi-tiered approach made it possible to check how the particles generate or modulate reactive oxygen species at different levels of complexity, from basic catalytic assays and free-radical detection to testing inside living cells.
For anyone choosing a degree, this is a good example of how physics, chemistry and biology have to sit at the same table in modern research.
“The main value of NESTOR is that it connected the physical chemistry of magnetic nanoparticles with their biological consequences. We were able to look at nanozymes not only as catalysts but as materials whose surface, magnetic and toxicological properties must be designed together,” the coordinator sums up.
According to Goya, a nanoparticle’s surface acts as a dense, magnetically addressable array of redox-active sites. By tuning the surface state of the iron oxide, researchers can control how electrons transfer to reactive species — in practice, how strongly the material works.
“Because these nanozymes are magnetic, they can be activated, guided, separated and reused using external fields. This gives them a massive practical advantage over many conventional catalysts in healthcare, environmental water treatment and industrial biotechnology,” Goya points out.
The next steps will focus on scaling up material production, standardising nanozyme activity metrics and advancing preclinical validations. The coordinator himself, however, sees the project’s greatest legacy elsewhere: “Perhaps the most enduring legacy of NESTOR is its collaborative spirit. The profound human quality and interdisciplinary synergy of the partners helped overcome complex administrative obstacles while also sparking at least seven new collaborative projects.”
Iron-oxide magnetic nanozymes imitate natural enzymes and can be steered with a magnet. The NESTOR team showed that their effectiveness and safety depend above all on the surface of the particles, not on producing ever more new variants. The most important lesson is simple: in catalysis, as in many other things, control and balance count for more than maximum power at any cost.
5 questions · one minute
EN 
CS
DE
ES
FR
HU
IT
PL
PT
РУ
SK
TR
УК
AR
中文